Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Effects of extracellular Granzyme B on pathological angiogenesis and tumorigenesis
FY 2014-15
Summary
Negative effects of extracellular Granzyme B in cancer.
Granzyme B (GzmB) is a protein degrading enzyme that is used by immune cells to kill infected cells and cancer cells. However, during excessive or chronic inflammation, GzmB leaks out and accumulates outside of the cells. This leads to degradation of many important extracellular matrix (ECM) proteins that form the scaffold for cells to bind to and hold tissues together keeping them functioning properly. GzmB is present in high amounts in the ECM in many diseases where immune response is excessive and uncontrolled, for example in chronic non-healing skin wounds, rheumatoid arthritis, cancer, and heart disease. It has been shown that decorin, an important protein of the ECM, has strong anti-cancer activity, and is believed to be a natural defense mechanism against cancer. As such, therapies that increase decorin have been proposed as a treatment for cancer. Our lab has shown that GzmB degrades decorin, among many other ECM proteins. This project will investigate the roles of extracellular GzmB in cancer, particularly whether the degradation of decorin by GzmB affects the progression of cancer growth. Our lab has shown that GzmB inhibition in non-healing skin wounds speeds up wound healing. Inhibiting GzmB in the ECM may increase the natural ability of decorin to inhibit cancer growth and may lead to improved cancer therapies.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
331242
Name
Merkulova Yulia
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effects of extracellular Granzyme B on pathological angiogenesis and tumorigenesis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Decorin; Epidermal Growth Factor Receptor; Extracellular Matrix; Granzyme B; Pathological Angiogenesis; Receptor Signaling; Tissue Injury
Abstract
Negative effects of extracellular Granzyme B in cancer.
Granzyme B (GzmB) is a protein degrading enzyme that is used by immune cells to kill infected cells and cancer cells. However, during excessive or chronic inflammation, GzmB leaks out and accumulates outside of the cells. This leads to degradation of many important extracellular matrix (ECM) proteins that form the scaffold for cells to bind to and hold tissues together keeping them functioning properly. GzmB is present in high amounts in the ECM in many diseases where immune response is excessive and uncontrolled, for example in chronic non-healing skin wounds, rheumatoid arthritis, cancer, and heart disease. It has been shown that decorin, an important protein of the ECM, has strong anti-cancer activity, and is believed to be a natural defense mechanism against cancer. As such, therapies that increase decorin have been proposed as a treatment for cancer. Our lab has shown that GzmB degrades decorin, among many other ECM proteins. This project will investigate the roles of extracellular GzmB in cancer, particularly whether the degradation of decorin by GzmB affects the progression of cancer growth. Our lab has shown that GzmB inhibition in non-healing skin wounds speeds up wound healing. Inhibiting GzmB in the ECM may increase the natural ability of decorin to inhibit cancer growth and may lead to improved cancer therapies.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Merkulova, Yulia
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~